Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zina Aladili
Observed names:
Aladili, Zina,
Z. Aladili
Institution:
Basildon Hospital
Observed institutions:
Basildon and Thurrock University Hospitals NHS Foundation Trust,
Southend University Hospital NHS Foundation Trust,
Southend Hospital,
Basildon Hospital,
Anglia Ruskin University
ORCID:
0000-0001-6981-5986
Observed ORCID:
0000-0001-6981-5986
OpenAlex ID:
A5066835091
Lymphovascular invasion in hormone-positive, human epidermal growth factor-negative, low-burden axillary disease in early breast cancer patients tested for oncotype DX recurrence score
2022
·
Abdalla Saad Abdalla Al-Zawi
, Su Lei Yin
, et al.
·
Współczesna Onkologia
·
11
PDF
The Oncotype DX Recurrence Score's Impact on the Management of Oestrogen-Positive/Human Epidermal Growth Factor Receptor 2-Negative, Low-Burden Axillary Status Breast Cancer (REHAB Study): Results of a Single Centre
2022
·
Abdalla Saad Abdalla Al-Zawi
, Su-Lei Yin
, et al.
·
Cureus
·
9
PDF
Correlation of Ki-67 proliferative index with oncotype DX recurrence score in hormone receptor-positive, human epidermal growth factor receptor 2-negative early breast cancer with low-burden axillary nodal disease – a review of 137 cases
2024
·
Abdalla Saad Abdalla Al-Zawi
, Kristina Arsenievna Anichkina
, et al.
·
Polish Journal of Pathology
·
7
PDF
The Challenge of COVID-19: The Biological Characteristics and Outcomes in a Series of 130 Breast Cancer Patients Operated on During the Pandemic
2020
·
Abdalla Saad Abdalla Al-zawi
, Amira Asaad
, et al.
·
Chirurgia
·
6
PDF
Evaluating the impact of genetic profiling on treatment outcomes in ER-positive, HER2-negative breast cancer: A meta-analysis and systematic review of chemotherapy and endocrine therapy
2025
·
Max Seabrook
, Ahamed Navas
, et al.
·
European Journal of Surgical Oncology
·
1
The correlation between the Oncotype DX recurrence score and Ki-67 proliferation index in ER+ve,HER2−ve, node negative breast cancer
2022
·
Abdalla Saad Abdalla Al-Zawi
, Marina Barron
, et al.
·
European Journal of Surgical Oncology
·
1
146 Retrospective audit of treatment outcomes from palliative thoracic radiotherapy – a single centre experience
2016
·
Z. Aladili
, D.J. Kearns
, et al.
·
Lung Cancer
·
1
Impact of Adjuvant Chemotherapy on Survival Outcomes in Intermediate‐ and High‐Risk ER+/HER2− Breast Cancer Stratified by Genomic Profiling: A Meta‐Analysis
2026
·
Max Seabrook
, Ahamed S. M. Navas
, et al.
·
International Journal of Breast Cancer
Ductal carcinoma in-situ influence on the Oncotype DX recurrence score and the adjuvant chemotherapy decision making in early breast cancer management
2025
·
A. Saad Abdalla
, M. Elamass
, et al.
·
European Journal of Surgical Oncology
Comparative Analysis of Oncotype DX Recurrence Scores in Screen‑Detected Versus Symptomatic Early‑Stage Breast Cancer: The COSSEB Study
2025
·
Abdalla Saad Abdalla Al-Zawi
, Beata Adamczyk
, et al.
·
Cureus
Abstract P5-09-24: Neoadjuvant (NA) immunotherapy (IO) combined with chemotherapy in triple negative breast cancer (TNBC): A UK real world experience from three centres
2025
·
Hossameldin Abdallah
, Bahaaeldin Baraka
, et al.
·
Clinical Cancer Research
The Oncotype DX Recurrence Score in low HER2 operable hormone receptor positive early breast cancer.
2024
·
A. Saad Abdalla Al-Zawi
, M. Elamass
, et al.
·
European Journal of Surgical Oncology
Relationship of histologic grade with oncotype Dx-recurrence score; a review of 176 early breast cancer cases
2024
·
A. Saad Abdalla Al-Zawi
, W. Ramadan
, et al.
·
European Journal of Surgical Oncology
The correlation between Oncotype Dx recurrence score and tumour size in oestrogen receptor positive , human epidermal growth factor receptor-2 negative early breast cancer
2024
·
Abdalla Saad Abdalla Al-Zawi
, Mohamed Elamass
, et al.
·
European Journal of Surgical Oncology
The correlation between Ki67 proliferative index and Oncotype Dx recurrence score in oestrogen receptor positive , human epidermal growth factor receptor-2 negative early breast cancer
2024
·
Abdalla Saad Abdalla Al-Zawi
, Mohamed Elamass
, et al.
·
European Journal of Surgical Oncology
Oligometastatic Breast cancer to the orbit presenting as right medial rectus palsy
2023
·
Reema Rasheed
, Kevin George
, et al.
·
European Journal of Surgical Oncology
Li-Fraumeni syndrome with breast cancer; a case report
2023
·
Mariam Elremeli
, Philip Idaewor
, et al.
·
European Journal of Surgical Oncology
The correlation between Clinicopathological criteria of node-positive breast cancer having upfront chemotherapy and the post-chemotherapy breast pathological response
2022
·
Amira Asaad
, Philip Idaewor
, et al.
·
European Journal of Surgical Oncology
Epidemiology, Incidence and Outcomes from Male breast cancer in Mid and South Essex
2021
·
Firas Eddin Alkistawi
, Qasif Qavi
, et al.
·
European Journal of Surgical Oncology
Breast adenoid cystic carcinoma in a 56-year-old female: a case report
2021
·
Rebecca Fisher
, Wayne Chicken
, et al.
·
European Journal of Surgical Oncology
Triple Negative Male Breast Cancer
2021
·
Qasif Qavi
, Rizwan Ahmed
, et al.
·
European Journal of Surgical Oncology
Show more works
View as search
Works count:
26
Citation count:
36
H-index:
4
I10-index:
1
Year
Topic
Type